Skip to content

A Single-Center, Randomized Controlled Exploratory Study on the Application of Dual-Point Guide Massage Combined with Analgesic Drugs in Pain Management for Osteosarcoma Patients

A Single-Center, Randomized Controlled Exploratory Study on the Application of Dual-Point Guide Massage Combined with Analgesic Drugs in Pain Management for Osteosarcoma Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110681
Enrollment
Unknown
Registered
2025-10-17
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients diagnosed with osteosarcoma presenting with moderate to severe pain, managed by the Department of Bone Oncology

Interventions

Intervention Group:Patients presenting with a pain score of =4 were managed with dual-acupoint guided massage in combination with three-step analgesic ladder therapy, an
Control group:Patients presenting with a pain score of =4 were managed with non-acupoint massage in combination with three-step analgesic ladder therapy, and the in

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. all patients had been diagnosed as osteosarcoma patients; age >= 12 years. 2. Patients complained of pain; pain risk score (Number Rating Scale (NRS)) >=4 on a scale of 0-10. 3. The patient was in a clear state of mind, had normal verbal ability, and was able to reasonably assess pain. 4. No serious organ dysfunction; no history of drug abuse. 5. Understand and sign the informed consent form for this study. 6. Be able to adhere to the treatment according to the planned course of treatment and be willing to cooperate with the study.

Exclusion criteria

Exclusion criteria: 1.Inability to evaluate pain due to mental or cognitive impairment. 2.Severe hepatorenal dysfunction. 3.Pain from non-cancerous causes; 4.Presence of severe local skin breakdown or inflammatory conditions at the site intended for massage. 5.Patients were excluded if they had a history of failing more than two prior treatments for severe cancer pain or were unresponsive to opioid analgesics, or if they were concurrently enrolled in another clinical study.

Design outcomes

Primary

MeasureTime frame
The change in pain score was measured at 8:00 on day 7 of the intervention, while for patients requiring analgesic medication, the measurement was taken at the specified time point after drug administ;

Secondary

MeasureTime frame
Use of analgesic agents;

Countries

China

Contacts

Public ContactZhang Xiaodan

Shanghai General Hospital

wzm1860@163.com+86 152 2189 9889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026